Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors

Liver Transplantation

Volumn 22, Issue 2, 2016, Pages 226-236

  Wong, Tiffany C L ^a   Fung, James Y Y ^a   Chok, Kenneth S H ^a   Cheung, Tan To ^a   Chan, Albert C Y ^a   Sharr, William W ^a   Dai, Wing Chiu ^a   Chan, See Ching ^a   Lo, Chung Mau ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HTK SOLUTION; PRESERVATION SOLUTION; UNIVERSITY OF WISCONSIN SOLUTION;

ABDOMINAL BLEEDING; ACUTE GRAFT REJECTION; ADULT; AGE; ARTICLE; BILE LEAKAGE; BRAIN DEATH; CADAVER DONOR; CHOLESTASIS; COLD ISCHEMIA; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE ASSESSMENT; ETHNICITY; FATTY LIVER; FEMALE; GENDER; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATIC ARTERY THROMBOSIS; HUMAN; HUMAN TISSUE; INTENSIVE CARE; ISCHEMIA; KIDNEY FAILURE; LENGTH OF STAY; LIVER BIOPSY; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDIAN MODEL FOR ENDEXCEPT LIVER DISEASE SCORE; MORTALITY; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURGICAL MORTALITY; ADOLESCENT; AGED; BIOPSY; CHILD; DONOR; END STAGE LIVER DISEASE; HOSPITALIZATION; LIVER; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; RISK; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOPSY; BRAIN DEATH; CHILD; CHILD, PRESCHOOL; COLD ISCHEMIA; CRITICAL CARE; END STAGE LIVER DISEASE; FATTY LIVER; FEMALE; GRAFT SURVIVAL; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84961289832     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24335     Document Type: Article

References (31)

1. Kim WR, Smith JM, Skeans MA, Schladt DP, Schnitzler MA, Edwards EB, et al., OPTN/SRTR 2012 annual data report: liver. Am J Transplant 2014; 14 (suppl 1): 69-96.
2. Cameron A, Busuttil RW,. AASLD/ILTS transplant course: is there an extended donor suitable for everyone? Liver Transpl 2005; 11 (suppl 2): S2-S5.
3. McCormack L, Dutkowski P, El-Badry AM, Clavien PA,. Liver transplantation using fatty livers: always feasible? J Hepatol 2011; 54: 1055-1062.
4. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al., Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993; 55: 807-813.
5. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al.,; for American Association for the Study of Liver Diseases, American College of Gastroenterology. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609.
6. Imber CJ, St Peter SD, Lopez I, Guiver L, Friend PJ,. Current practice regarding the use of fatty livers: a trans-Atlantic survey. Liver Transpl 2002; 8: 545-549.
7. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, et al., Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47: 903-905.
8. Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, et al., Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003; 9: 500-505.
9. Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, et al., The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 2010; 16: 874-884.
10. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J,. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94: 78-86.
11. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
12. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al., The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-196.
13. United Network for Organ Sharing. http://www.unos.org. Accessed October 25, 2015.
14. Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, et al., Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010; 16: 943-949.
15. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al., Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
16. Chung IS, Kim HY, Shin YH, Ko JS, Gwak MS, Sim WS, et al., Incidence and predictors of post-reperfusion syndrome in living donor liver transplantation. Clin Transplant 2012; 26: 539-543.
17. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl (2011) 2012; 2: 1-138.
18. Gõmez MP, Pérez B, Manyalich M,. International Registry in Organ Donation and Transplantation - 2013. Transplant Proc 2014; 46: 1044-1048.
19. Noujaim HM, de Ville de Goyet J, Montero EF, Ribeiro CM, Capellozzi VL, Crescentini F, et al., Expanding postmortem donor pool using steatotic liver grafts: a new look. Transplantation 2009; 87: 919-925.
20. Adam R, Reynes M, Johann M, Morino M, Astarcioglu I, Kafetzis I, et al., The outcome of steatotic grafts in liver transplantation. Transplant Proc 1991; 23 (pt 2): 1538-1540.
21. Markin RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, Hirst K, Shaw BW Jr,. Frozen section evaluation of donor livers before transplantation. Transplantation 1993; 56: 1403-1409.
22. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA,. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007; 246: 940-946.
23. Frongillo F, Avolio AW, Nure E, Mulè A, Pepe G, Magalini SC, Agnes S,. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival. Transplant Proc 2009; 41: 1268-1272.
24. Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, et al., Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997; 64: 248-251.
25. Ureña MA, Ruiz-Delgado FC, González EM, Segurola CL, Romero CJ, García IG, et al., Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc 1998; 30: 3288-3291.
26. Yoong KF, Gunson BK, Neil DA, Mirza DF, Mayer AD, Buckels JA, McMaster P,. Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc 1999; 31: 550-551.
27. Zamboni F, Franchello A, David E, Rocca G, Ricchiuti A, Lavezzo B, et al., Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 2001; 15: 53-57.
28. Johnson RJ, Bradbury LL, Martin K, Neuberger J,; for UK Transplant Registry. Organ donation and transplantation in the UK-the last decade: a report from the UK national translant registry. Transplantation 2014; 97 (suppl 1): S1-S27.
29. Baccarani U, Isola M, Adani GL, Avellini C, Lorenzin D, Rossetto A, et al., Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications. Clin Transplant 2010; 24: 631-635.
30. Moon D, Lee S, Hwang S, Kim K, Ahn C, Park K, et al., Resolution of severe graft steatosis following dual-graft living donor liver transplantation. Liver Transpl 2006; 12: 1156-1160.
31. Li J, Liu B, Yan LN, Zuo YX, Li B, Zeng Y, et al., Reversal of graft steatosis after liver transplantation: prospective study. Transplant Proc 2009; 41: 3560-3563.